The Department of Pharmacology and Cancer Biology was created to foster collaborative interactions between scientists with different, though complementary, research interests and expertise. The primary goal in developing such an interdisciplinary department was to create an environment where rigorous scientific debate and discourse between researchers with different perspectives would create a stimulating and productive intellectual environment for faculty and trainees alike. As you browse through the research descriptions of our faculty and appreciate the breadth and significance of their scientific achievements, it should become clear that this experiment was a tremendous success. Research projects address a myriad of important scientific questions relevant to cancer, metabolism, nervous system function, drugs of abuse, and environmental toxicants. However, one unifying theme that has emerged in the department is cell signaling and the use of pharmacological approaches to define the key regulatory steps in relevant pathways that may be amenable to pharmaceutical exploitation or whose dysregulation may be involved in the pathogenesis of disease. It is a privilege to welcome you to our website and we encourage you to learn more about the opportunities in research, training, and education offered by this exciting and dynamic department.
Donald P. McDonnell, Ph.D.
Professor and Chairman


  • Wednesday, March 25, 2015 at 12:00 pm

  • Jeff Settleman, Ph.D., Genentech
  • "The role of "heterogeneity" in tumor evolution and treatment response"
  • 103 Bryan Research Building
  • Thursday, March 26, 2015 at 2:00 pm

  • Abigail Brunner (Advisor: Donald McDonnell)
  • “Targeting Histone Deacetylases in Advanced Prostate Cancer”
  • 143 Jones
  • Friday, March 27, 2015 at 2:00 pm

  • Leonor Añó (Advisor: David Kirsch)
  • “Using Novel Genetically Engineered Mouse Models of Soft Tissue Sarcoma to Interrogate the Contribution of Cell of Origin and Tissue Injury to Sarcoma Development”
  • 143 Jones
  • Monday, March 30, 2015 at 1:30 pm

  • Priyaanka Nanduri (Advisor: Pang Yao)
  • “Passing the Baton: The Switch from Proteasomes to Autophagy in Aggresome Processing"
  • 143 Jones Building
  • Wednesday, April 1, 2015 at 12:00 pm

  • David Tuveson, MD, PhD, Cold Spring Harbor Laboratory
  • "New models for pancreatic cancer medicine"
  • 103 Bryan Research Building
  • Thursday, April 2, 2015 at 1:00 pm

  • Edward Zhu (Advisor: Rebecca Yang)
  • “Circuit and behavioral basis of egg-laying site selection in Drosophila melanogaster”
  • 143 Jones
  • Wednesday, April 8, 2015 at 12:00 pm

  • William Hahn, M.D., Ph.D., Dana-Farber Cancer Institute
  • "Systematic functional approaches to identify cancer targets and pathways"
  • 103 Bryan Research Building
  • Wednesday, April 15, 2015 at 12:00 pm

  • Sean Morrison, Ph.D., UT Southwestern Medical Center
  • "New approaches to melanoma therapy"
  • 103 Bryan Research Building
[ All Upcoming Seminars ]

© 2012 Pharmacology and Cancer Biology. Duke University School of Medicine. Site design: Academic Web Pages